Search research articles
Contact Us
Filters
Showing results (161-170 of 342) with videos related to
Page
of 35
Sort By:
Annals of the Rheumatic Diseases
|
May 20, 2018
Response to: 'To DAPSA or not to DAPSA? That is not the question' by Schoels <i>et al</i>
Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, et al.
The Lancet. Rheumatology
|
March 25, 2026
Development of patient-initiated follow-up resources for UK rheumatology departments: a co-design study with patient and clinician collaboration
Alice E Jennings, Ailsa Bosworth, Mel Brooke, et al.
The Journal of Rheumatology
|
May 3, 2017
Tackling Patient Centricity: A Report from the GRAPPA 2016 Annual Meeting
Niti Goel, Denis O'Sullivan, Ingrid Steinkoenig, et al.
Annals of the Rheumatic Diseases
|
December 18, 2020
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
Xenofon Baraliakos, Laure Gossec, Effie Pournara, et al.
Rheumatology (Oxford, England)
|
May 16, 2024
Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies
Laure Gossec, Ana-Maria Orbai, Maarten de Wit, et al.
Clinical Therapeutics
|
August 4, 2023
Lifestyle Modifications and Nonpharmacologic Interventions to Improve Outcomes in Psoriatic Arthritis: A Systematic Review
Louise H Hailey, Raj Amarnani, Chris Bundy, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2019
Best-practice Indicators in Psoriatic Disease Care
Philip S Helliwell, Guillaume Favier, Dafna D Gladman, et al.
The British Journal of Dermatology
|
March 8, 2022
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis
Kristian Reich, Xenophon Baraliakos, Laura C Coates, et al.
Trials
|
January 10, 2023
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
Christopher T Ritchlin, Laura C Coates, Philip J Mease, et al.
Nature Reviews. Disease Primers
|
August 13, 2021
Psoriatic arthritis
Oliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Page
of 35
Search research articles
Search
Showing results (161-170 of 342) with videos related to
Sort By:
Page
of 35
Annals of the Rheumatic Diseases
|
May 20, 2018
Response to: 'To DAPSA or not to DAPSA? That is not the question' by Schoels <i>et al</i>
Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, et al.
The Lancet. Rheumatology
|
March 25, 2026
Development of patient-initiated follow-up resources for UK rheumatology departments: a co-design study with patient and clinician collaboration
Alice E Jennings, Ailsa Bosworth, Mel Brooke, et al.
The Journal of Rheumatology
|
May 3, 2017
Tackling Patient Centricity: A Report from the GRAPPA 2016 Annual Meeting
Niti Goel, Denis O'Sullivan, Ingrid Steinkoenig, et al.
Annals of the Rheumatic Diseases
|
December 18, 2020
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
Xenofon Baraliakos, Laure Gossec, Effie Pournara, et al.
Rheumatology (Oxford, England)
|
May 16, 2024
Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies
Laure Gossec, Ana-Maria Orbai, Maarten de Wit, et al.
Clinical Therapeutics
|
August 4, 2023
Lifestyle Modifications and Nonpharmacologic Interventions to Improve Outcomes in Psoriatic Arthritis: A Systematic Review
Louise H Hailey, Raj Amarnani, Chris Bundy, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2019
Best-practice Indicators in Psoriatic Disease Care
Philip S Helliwell, Guillaume Favier, Dafna D Gladman, et al.
The British Journal of Dermatology
|
March 8, 2022
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis
Kristian Reich, Xenophon Baraliakos, Laura C Coates, et al.
Trials
|
January 10, 2023
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
Christopher T Ritchlin, Laura C Coates, Philip J Mease, et al.
Nature Reviews. Disease Primers
|
August 13, 2021
Psoriatic arthritis
Oliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Page
of 35